|
PRKAR1A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.77109998783709E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.05080000034619E-07 |
| Normal-vs-Stage2 |
7.821100E-03 |
| Normal-vs-Stage3 |
6.387500E-04 |
| Normal-vs-Stage4 |
1.134430E-01 |
| Stage1-vs-Stage2 |
7.493000E-01 |
| Stage1-vs-Stage3 |
8.758600E-01 |
| Stage1-vs-Stage4 |
8.330200E-01 |
| Stage2-vs-Stage3 |
8.516800E-01 |
| Stage2-vs-Stage4 |
9.836800E-01 |
| Stage3-vs-Stage4 |
9.070000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.12599995572805E-09 |
| Normal-vs-AfricanAmerican |
1.49620000000628E-06 |
| Normal-vs-Asian |
2.343200E-03 |
| Caucasian-vs-AfricanAmerican |
9.808800E-01 |
| Caucasian-vs-Asian |
8.855800E-01 |
| AfricanAmerican-vs-Asian |
8.565400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.66560123868476E-11 |
| Normal-vs-Female |
3.115600E-02 |
| Male-vs-Female |
6.843400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.755480E-03 |
| Normal-vs-Extreme_Weight |
1.70449999670197E-08 |
| Normal-vs-Obese |
5.8351999998596E-07 |
| Normal-vs-Extreme_Obese |
4.446200E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.888200E-01 |
| Normal_Weight-vs-Obese |
8.468000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.200600E-01 |
| Extreme_Weight-vs-Obese |
2.422600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.091400E-01 |
| Obese-vs-Extreme_Obese |
8.529800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.029840E-01 |
| Normal-vs-Age(41-60Yrs) |
5.6123000000019E-05 |
| Normal-vs-Age(61-80Yrs) |
2.29769980819583E-10 |
| Normal-vs-Age(81-100Yrs) |
1.9377000004539E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.093200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.012980E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.119700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.345700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.655700E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.119440E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.34370004012396E-09 |
| Normal-VS-Type2 PRCC |
4.07420000003711E-06 |
| Normal-VS-KIRP CIMP |
4.550000E-01 |
| Normal-VS-Unclassified PRCC |
4.177700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
7.033000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.610800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.262200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.771000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.350000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.364200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.68120000032523E-07 |
| Normal-vs-N1 |
4.45460000000342E-05 |
| Normal-vs-N2 |
7.180400E-01 |
| N0-vs-N1 |
7.641400E-01 |
| N0-vs-N2 |
6.107400E-01 |
| N1-vs-N2 |
6.556000E-01 |
|
|
